6533b7d2fe1ef96bd125f5aa

RESEARCH PRODUCT

Managing cancer patients during the COVID-19 pandemic:an ESMO multidisciplinary expert consensus

G. CuriglianoS. BanerjeeA. CervantesM.c. GarassinoP. GarridoN. GirardJ. HaanenK. JordanF. LordickJ.p. MachielsO. MichielinS. PetersJ. TaberneroJ.y. DouillardG. PentheroudakisA. AddeoL. AlbigesP.a. AsciertoS. BanerjeeF. BarlesiC. CaldasF. CardosoA. CervantesI.f. ChabernyN.i. ChernyT.k. ChoueiriM.l.k. ChuaC. CriscitielloG. CuriglianoE. De AzambujaD. De RuysscherE. De VriesR. DentJ.y. DouillardD. D’ugoR. DziadziuszkoC. Faivre-finnE. FelipM. GarassinoP. GarridoN. GirardR. Glynne-jonesV. GolfinopoulosJ. HaanenE. HamiltonP.a. JänneK. JordanR. KanesvaranS.b. KimU.g. LiebertF. LordickJ.p. MachielsO. MichielinT.s.k. MokG. MorganR. ObermannovaK. ParkA. PassaroG. PentheroudakisS. PetersM. ReckR. Salazar SolerF. ScottéS. SenanC. SessaE. SmythR. SooJ.c. SoriaJ. SpicerF. StrasserJ. TaberneroD.s.w. TanD. TrapaniE. Van CutsemH. Van HalterenP.e. Van SchilG. VeronesiJ. Yang

subject

0301 basic medicinemedicine.medical_specialtyConsensusCoronavirus disease 2019 (COVID-19)Settore MED/18 - CHIRURGIA GENERALEPneumonia ViraleducationDiseaseMedical OncologyReal-Time Polymerase Chain ReactionSpecial Article03 medical and health sciencesBetacoronavirus0302 clinical medicineMultidisciplinary approachNeoplasmsPandemicGranulocyte Colony-Stimulating FactorMedicineHumansDisease management (health)PandemicsSocieties Medicalbusiness.industrySARS-CoV-2Expert consensusCOVID-19Disease ManagementcovidHematologyTelemedicineEurope030104 developmental biologyOncology030220 oncology & carcinogenesisFamily medicineCancer managementSevere acute respiratory syndrome coronavirusbusinessCoronavirus InfectionsT-Lymphocytes Cytotoxic

description

We established an international consortium to review and discuss relevant clinical evidence in order to develop expert consensus statements related to cancer management during the severe acute respiratory syndrome coronavirus 2-related disease (COVID-19) pandemic. The steering committee prepared 10 working packages addressing significant clinical questions from diagnosis to surgery. During a virtual consensus meeting of 62 global experts and one patient advocate, led by the European Society for Medical Oncology, statements were discussed, amended and voted upon. When consensus could not be reached, the panel revised statements until a consensus was reached. Overall, the expert panel agreed on 28 consensus statements that can be used to overcome many of the clinical and technical areas of uncertainty ranging from diagnosis to therapeutic planning and treatment during the COVID-19 pandemic.

yearjournalcountryeditionlanguage
2020-10-01
10.1016/j.annonc.2020.07.010https://research.vumc.nl/en/publications/0c86f1b4-297a-4ee5-a25a-205957a80d8b